The influence of infertility treatment on the prognosis of endometrial cancer and atypical complex endometrial hyperplasia

International Journal of Gynecological Cancer

Volumn 23, Issue 2, 2013, Pages 288-293

  Ichinose, Mari ^a   Fujimoto, Akihisa ^a   Osuga, Yutaka ^a   Minaguchi, Takeo ^b   Kawana, Kei ^a   Yano, Tetsu ^a   Kozuma, Shiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Ochanomizu University   (Japan)

Author keywords

Controlled ovarian stimulation; Endometrial cancer; Ovulation induction; Recurrence

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; ATYPICAL COMPLEX ENDOMETRIAL HYPERPLASIA; CANCER PROGNOSIS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONCEPTION; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DRUG MEGADOSE; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; FEMALE INFER; HUMAN; HYSTERECTOMY; INFERTILITY THERAPY; MENSTRUAL IRREGULARITY; OUTCOME ASSESSMENT; OVULATION INDUCTION; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SAFETY; TREATMENT RESPONSE;

ADULT; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INFERTILITY, FEMALE; PREGNANCY; PREGNANCY RATE; PROGNOSIS; REPRODUCTIVE TECHNIQUES, ASSISTED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84876249966     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31827c18a1     Document Type: Article

References (19)

1. Pellerin GP, Finan MA. Endometrial cancer in women 45 years of age or younger: A clinicopathological analysis. Am J Obstet Gynecol. 2005;193:1640-1644.
2. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer. 1985;56:403-412.
3. Ushijima K, Yahata H, Yoshikawa H, et al. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol. 2007;25:2798-2803.
4. Elizur SE, Beiner ME, Korach J, et al. Outcome of in vitro fertilization treatment in infertile women conservatively treated for endometrial adenocarcinoma. Fertil Steril. 2007;88: 1562-1567.
5. Hahn HS, Yoon SG, Hong JS, et al. Conservative treatment with progestin and pregnancy outcomes in endometrial cancer. Int J Gynecol Cancer. 2009;19:1068-1073.
6. Brinton LA, Moghissi KS, Scoccia B, et al. Ovulation induction and cancer risk. Fertil Steril. 2005;83:261-274;quiz 525-6.
7. Modan B, Ron E, Lerner-Geva L, et al. Cancer incidence in a cohort of infertilewomen.AmJ Epidemiol. 1998;147:1038-1042.
8. Venn A, Watson L, Bruinsma F, et al. Risk of cancer after use of fertility drugs with in-vitro fertilization. Lancet. 1999;354: 1586-1590.
9. Althuis MD, Moghissi KS, Westhoff CL, et al. Uterine cancer after use of clomiphene citrate to induce ovulation. Am J Epidemiol. 2005;161:607-615.
10. Chao AS, Chao A, Wang CJ, et al. Obstetric outcomes of pregnancy after conservative treatment of endometrial cancer: Case series and literature review. Taiwan J Obstet Gynecol. 2011;50:62-66.
11. Chiva L, Lapuente F, Gonzalez-Cortijo L, et al. Sparing fertility in young patients with endometrial cancer. Gynecol Oncol. 2008;111:S101-S104.
12. Tangjitgamol S, Manusirivithaya S, Hanprasertpong J. Fertility-sparing in endometrial cancer. Gynecol Obstet Invest. 2009;67:250-268.
13. Badawy A, Gibreal A. Clomiphene citrate versus tamoxifen for ovulation induction in women with PCOS: A prospective randomized trial. Eur J Obstet Gynecol Reprod Biol. 2011; 159:151-154.
14. Badawy A, Abdel Aal I, Abulatta M. Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: A prospective randomized trial. Fertil Steril. 2009;92:849-852.
15. Han AR, Kwon YS, Kim DY, et al. Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endometrial adenocarcinoma or atypical complex hyperplasia. Int J Gynecol Cancer. 2009;19:147-151.
16. Niwa K, Tagami K, Lian Z, et al. Outcome of fertility-preserving treatment in young women with endometrial carcinomas. BJOG. 2005;112:317-320.
17. Yu M, Yang JX, Wu M, et al. Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium. Fertil Steril. 2009;92:2122-2124.
18. Wu HM, Lai CH, Huang HY, et al. A successful live twin birth by in vitro fertilization after conservative treatment of recurrent endometrial cancer. Chang Gung Med J. 2008;31:102-106.
19. Perri T, Korach J, Gotlieb WH, et al. Prolonged conservative treatment of endometrial cancer patients: More than 1 pregnancy can be achieved. Int J Gynecol Cancer. 2011;21:72-78.